Orsiro may be the new benchmark for comparison in drug-eluting stent trials
At the 2018 Transcatheter Cardiovascular Therapeutics (TCT) meeting (21–25 September, San Diego, USA), David Kandzari (Piedmont Heart Institute, Atlanta, USA) presented the two-year results...
BASILICA: A new approach for preventing coronary obstruction in TAVI
Insufficient blood flow towards the coronary vasculature following transcatheter aortic valve implantation (TAVI) is a dreadful complication. This can result in a wide spectrum...
The resurgence of renal denervation
More than ever before, arterial hypertension represents one of the greatest health threats and challenges for both patients and treating physicians. With the new...
EACTS 2018: From bench to bedside: Roundtrip for cell therapy in heart disease
The study of stem cells in regenerative medicine is a growing field of basic and clinical research, generating a broad interest and debate in...
(Visited 1,620 times, 1 visits today)
